Skip to Content
MedicinesMedicines
  • Correction
  • Open Access

19 November 2026

2 Pages

Correction: Silva et al. Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review. Medicines 2024, 11, 20

,
,
and
1
Unidade Local de Saúde (ULS) de Coimbra, 3004-561 Coimbra, Portugal
2
Polytechnic Institute of Coimbra, Coimbra Health School, Farmácia, 3046-854 Coimbra, Portugal
3
QLV Research Consulting, 3030-193 Coimbra, Portugal
*
Author to whom correspondence should be addressed.
Table Correction
In the original publication [1], there was a citation error in Table 1. The bullet point “Increase glucose transport in the [46,54]” incorrectly included reference [54]. Reference [54] has been removed from this specific citation, and the text has been corrected to “Increase glucose transport [46]”.
References Correction
In the original publication [1], References 43, 62, 72, 84 and 95 were not the most appropriate sources to support the Review.
The references have been corrected as follows:
References numbered 72 and 95 have been removed.
References numbered 43, 62, and 84 have been replaced with the following references:
43. Sisinni, L.; Landriscina, M. The role of human chorionic gonadotropin as tumor marker: Biochemical and clinical aspects. In Advances in Cancer Biomarkers: From Biochemistry to Clinic for a Critical Revision; Scatena, R., Ed.; Springer: Dordrecht, The Netherlands, 2015; pp. 159–176. https://doi.org/10.1007/978-94-017-7215-0_11.
62. Tauchen, J.; Jurášek, M.; Huml, L.; Rimpelová, S. Medicinal Use of Testosterone and Related Steroids Revisited. Molecules 2021, 26, 1032. https://doi.org/10.3390/molecules26041032.
The original reference [84] has been updated to the current reference [83]: Ip, E.J.; Yadao, M.A.; Shah, B.M.; Lau, B. Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users. AIDS Care 2016, 28, 294–299. https://doi.org/10.1080/09540121.2015.1090539.
The order of the other references has been adjusted according to the correction. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Silva, V.; Madeira, R.; Joaquim, J.; Matos, C. Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review. Medicines 2024, 11, 20. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.